Antitumor Activities and Immunomodulatory Effects of Ginseng Neutral Polysaccharides in Combination with 5-Fluorouracil

被引:84
|
作者
Ni, Weihua [1 ]
Zhang, Xu [1 ]
Wang, Bo [1 ,2 ]
Chen, Yan [1 ,3 ]
Han, Han [1 ]
Fan, Yuying [1 ]
Zhou, Yifa [1 ]
Tai, Guihua [1 ]
机构
[1] NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China
[2] Beihua Univ, Coll Chem & Biol, Jilin, Peoples R China
[3] Baicheng Med Coll, Baicheng, Peoples R China
基金
中国国家自然科学基金;
关键词
antitumor activity; chemoprotective effect; ginseng; immunological activity; polysaccharides; BIOLOGICAL RESPONSE MODIFIERS; MACROPHAGE ACTIVATION; ACIDIC POLYSACCHARIDE; PANAX-GINSENG; IN-VIVO; CHONDRUS-OCELLATUS; PHELLINUS-LINTEUS; BETA-GLUCAN; IMMUNOTHERAPY; MECHANISM;
D O I
10.1089/jmf.2009.1119
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A neutral polysaccharide fraction (WGPN) prepared from Panax ginseng C. A. Meyer by hot water extraction and DEAE-cellulose chromatography was tested for its anticancer activity alone and in combination with 5-fluorouracil (5-FU) in Sarcoma-180 (S180) tumor-bearing mice by intragastric administration. WGPN alone inhibited S180 tumor growth in a bell-shaped dose-response curve, and the combination with 5-FU showed a synergistic effect. Studies of various immunological activities in S180-bearing mice revealed that WGPN stimulated the proliferation of lymphocytes, increased natural killer cell cytotoxicity, enhanced the phagocytosis and nitric oxide production by macrophages, and increased the level of tumor necrosis factor-a in serum. In combination with 5-FU, WGPN mitigated damage to the immune system caused by 5-FU in S180-bearing mice. These results suggest that WGPN might be a potential adjuvant for chemotherapeutic drugs.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 50 条
  • [21] Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma
    Enjoji, Munechika
    Morizono, Shusuke
    Kotoh, Kazuhiro
    Kohjima, Motoyuki
    Miyagi, Yuzuru
    Yoshimoto, Tsuyoshi
    Nakamuta, Makoto
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (36) : 5685 - 5687
  • [22] Synthesis and antitumor activity of 5-fluorouracil derivatives
    Ozaki, S
    MEDICINAL RESEARCH REVIEWS, 1996, 16 (01) : 51 - 86
  • [23] Simultaneous, but not consecutive combination with folinate salts potentiates 5-fluorouracil antitumor activity in vitro
    Di Paolo, A.
    Orlandi, P.
    Di Desidero, T.
    Danesi, R.
    Bocci, G.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S68 - S68
  • [24] COMPARATIVE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL AND ITS PRODRUGS IN COMBINATION WITH HYPERTHERMIA INVITRO
    SHIIKI, S
    FUCHIMOTO, S
    IWAGAKI, H
    AKAZAI, Y
    MATSUBARA, N
    WATANABE, T
    ORITA, K
    ACTA MEDICA OKAYAMA, 1991, 45 (05) : 339 - 345
  • [25] In vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer
    Inoue, Y
    Tanaka, K
    Hiro, J
    Yoshiyama, S
    Toiyama, Y
    Eguchi, T
    Miki, C
    Kusunoki, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (02) : 479 - 486
  • [26] 5-FLUOROURACIL DERIVATIVES .9. SYNTHESIS AND ANTITUMOR ACTIVITIES OF "(ALKYLTHIO)CARBONYL-5-FLUOROURACILS
    HOSHIKO, T
    OZAKI, S
    WATANABE, Y
    OGASAWARA, T
    YAMAUCHI, S
    FUJIWARA, K
    HOSHI, A
    IIGO, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1985, 33 (07) : 2832 - 2837
  • [27] 5-FLUOROURACIL DERIVATIVES .10. SYNTHESIS AND ANTITUMOR ACTIVITIES OF ALPHA-ALKOXYALKYL-5-FLUOROURACILS
    OZAKI, S
    WATANABE, Y
    HOSHIKO, T
    NAGASE, T
    OGASAWARA, T
    FURUKAWA, H
    UEMURA, A
    ISHIKAWA, K
    MORI, H
    HOSHI, A
    IIGO, M
    TOKUZEN, R
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (01) : 150 - 157
  • [28] NOVEL DERIVATIVES OF 5-FLUOROURIDINE AND 5-FLUOROURACIL HAVING POTENT ANTITUMOR AND LOWER IMMUNOSUPPRESSIVE ACTIVITIES
    MORI, H
    SAKAMOTO, O
    KITAICHI, K
    KODA, A
    KITA, J
    JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 58 (03): : 269 - 282
  • [29] 5-fluorouracil derivatives .22. Synthesis and antitumor activities of 1-carbamoyl-5-fluorouracils
    Ozaki, S
    Kong, XZ
    Watanabe, Y
    Hoshiko, T
    Koga, T
    Ogasawara, T
    Takizawa, T
    Fujisawa, H
    Iigo, M
    Hoshi, A
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (08) : 1372 - 1375
  • [30] Antitumor effects of a cyclooxygenase-2 inhibitor, meloxicam, alone and in combination with radiation and/or 5-fluorouracil in cultured tumor cells
    Ayakawa, Shiho
    Shibamoto, Yuta
    Sugie, Chikao
    Ito, Masato
    Ogino, Hiroyuki
    Tomita, Natsuo
    Kumagai, Masaoki
    Murakami, Hiromi
    Sawa, Hiroki
    MOLECULAR MEDICINE REPORTS, 2009, 2 (04) : 621 - 625